Search for: "BRISTOL-MYERS SQUIBB COMPANY" Results 201 - 220 of 469
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Jun 2009, 6:17 pm
  This brought to mind the  Tequin recall by Bristol-Myers Squibb (BMS) in April 2006. [read post]
28 May 2008, 8:56 am
"There's not been a default but there's a complete loss of liquidity.'' In January, Bristol-Myers Squibb booked unrealized pretax losses of $142 million on $811 million of ARS, (It also replaced its treasurer.) [read post]
28 Jul 2009, 1:11 pm
Some of the lawyers come from impressive backgrounds, including a former senior patent attorney at Bristol-Myers Squibb and a venture capitalist who worked at GE Asset Management. [read post]
11 Feb 2011, 1:30 pm by Lucas A. Ferrara, Esq.
Batts United States District Judge, Southern District of New York Sandra Leung General Counsel and Corporate Secretary, Bristol-Myers Squibb Michele Coleman Mayes Senior Vice President and General Counsel, Allstate Insurance Company Hon. [read post]
24 Jan 2007, 9:59 pm
It was also recently reported that Lek D.D., a subsidiary of Sandoz, filed a complaint for patent infringement against Bristol-Myers Squibb and Watson Pharmaceuticals relating to BMS's Pravachol (pravastatin sodium). [read post]
26 Apr 2011, 10:30 pm
Many cases are likely to be filed in New Jersey state court, where Sanofi-Aventis is headquartered and Bristol Myers Squibb has five facilities. [read post]
29 Feb 2012, 7:24 am
Squibbs and Sons (now known as Bristol-Myers Squibb) and many other companies including 70 other similar types of synthetic hormones . [read post]
9 Apr 2010, 1:52 pm by Alain Leibman
., Apr. 7, 2010) involves the prosecution of two former top executives of Bristol-Myers Squibb. [read post]
9 Aug 2010, 3:07 pm
--Collazo v Bristol-Myers Squibb Manufacturing, Inc, (1st Circuit): An interesting one here. [read post]
9 Aug 2006, 9:46 am
This is the latest development in a legal morass that has developed between Apotex and the brand name drug co-marketers, Sanofi-Aventis SA and Bristol-Myers Squibb Co., after their deal that would have delayed bringing a generic to market for another five years was blocked. [read post]
28 Aug 2009, 8:11 am
(patent infringement) 8/28: Bristol-Myers Squibb Co., Bristol-Myers Squibb Pharma Co. v. [read post]
26 Jun 2015, 11:30 am
  Our readers already know that it took the California Supreme Court less than four months to depublish Bristol-Myers Squibb (reported here). [read post]
12 Dec 2013, 7:12 am
 In the meantime, here they are in outline:Case C‑443/12, Actavis Group PTC EHF, Actavis UK Ltd v Sanofi, Sanofi Pharma Bristol-Myers Squibb SNC intervening, noted on The SPC Blog here. [read post]
1 Aug 2013, 9:29 am by Derek T. Braslow
The generic and brand names of the drugs in this family include: • Exenatide (Byetta & Bydureon) marketed by Bristol Myers-Squibb and Amylin Pharmaceuticals, Inc. [read post]